Inverse relationship of serum IL-17 with type-II diabetes retinopathy

Clinical Laboratory

Volumn 59, Issue 11-12, 2013, Pages 1311-1317

  Afzal, Nadeem ^a   Javaid, Khursheed ^a   Sami, Waqas ^a   Zafar, Abu ^b   Jahan, Shah ^a   Zaman, Shakeela ^c   Nagi, A H ^a  

^a UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

^b Amin Hayat Memorial Diabetic Centre   (Pakistan)

^c CHILDREN S HOSPITAL   (Pakistan)

Author keywords

Cytokine; Diabetes mellitus; Inflammation; Retinopathy

Indexed keywords

HEMOGLOBIN A1C; INTERLEUKIN 17;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC RETINOPATHY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; YOUNG ADULT;

ADULT; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-17; MALE; MIDDLE AGED;

EID: 84891602028     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2013.121140     Document Type: Article

References (38)

1. World Health Organization Expert Committee. Report of a WHO consultation part 1:diagnosis and classification of diabetes mellitus. 1999. WHO, Geneva.
2. Danaei G, Fried AB, Oza S, Murray CJL, Ezzati M. Diabetes prevalence anddiagnosis in US states: analysis of health surveys. Population Health Metrics. 2009;7:16.
3. Qidwai W, Ashfaq T. Imminent epidemic of diabetes mellitus in Pakistan: Issues and challenges for health care providers. JLUMHS. 2010;9(3):112-3
4. Singh R, Shaw J, Zimmet P. Epidemiology of childhood type 2 diabetes in the developing world. PediatrDiabetes 2004;5:154-68. (Pubitemid 39405988)
5. Chan JCN, Malik V, Jia W, et al. Diabetes in Asia: Epidemiology, risk factors and pathophysiology. JAMA;2009;301(20):2129-40.
6. Wild S, Roglic G, Green A. Global Prevalence of Diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27(5):1047-53. (Pubitemid 38579764)
7. Funatsu H, Yamashita H, Noma H, et al. Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients. Arch Clin Exp Ophthalmol 2005;243:3-8.
8. King GL. The role of inflammatory cytokines in diabetes and its complications. J Periodontol 2008;79:1527-34.
9. Kastelan S, Zjacic-RV, Kastelan Z. Could diabetic retinopathy be an autoimmune disease? Medical Hypotheses 2007;68:1016-8. (Pubitemid 46274046)
10. Meleth AD, Agron E, Chan C, et al. Serum inflammatory markers in diabetic retinopathy. Investigative Ophthalmology & Visual Science 2005;46:4295-301. (Pubitemid 44264635)
11. Rachitskaya AV, Hansen AM, Horai R, et al. Cutting Edge: NKT Cells Constitutively Express IL-23 Receptor and RORγt and Rapidly Produce IL-17 upon Receptor Ligation in an IL-6 Independent Fashion. The Journal of Immunology 2008;180:5167-71.
12. Voo KS, Wang YH, Santori FR, et al. Identification of IL-17 producing FOXP3+ regulatory T cells in humans. PNAS 2009;106(12):4793-8.
13. Honkanen J, Nieminen JK, Gao R, et al. IL-17 Immunity in Human Type 1 Diabetes. The Journal of Immunology 2010;185:1959-67.
14. Zeng C, Xiaoyun S, Baojun Z, et al. The imbalance of Th17/Th1/Tregs in patients with type 2 diabetes: relationship with metabolic factors and complications. J Mol Med 2012;90:175-86.
15. Akram J, Aamir Aziz-ul-H, Basit A, et al. Prevalence of peripheral arterial disease in type 2 diabetes in Pakistan. JPMA 2011;61(7):644-8.
16. Chhutto MA, Qadar Habib-ur-R, Abro HA, et al. Awareness of diabetes mellitus and its complications in diabetic patients. Medical Channel 2009;15(4):153-6.
17. Ahmadani MY, Fawwad A, Basit A, Hydrie ZI. Microalbuminuria Prevalence Study in Hypertensive Patients with Type 2 Diabetes in Pakistan. J Ayub Med Coll Abbottabad 2008;20(3):117-20.
18. Jamal-u-D, Qureshi MB, Khan AJ, Khan MD, Ahmad K. Prevalence of diabetic retinopathy among individuals screened positive for diabetes in five community-based eye camps in northern Karachi Pakistan. J Ayub Med Coll Abbotabad 2006;18(3):40-3.
19. Tam VHK, Lam EPK, Chu BCY, Tse KK, Fung LM. Incidence and progression of diabetic retinopathy in Homg Kong Chinese with ty pe 2 diabetes mellitus. Journal of Diabetes and its Complications 2008;23(3):185-93.
20. Khan S, Abbas M, Habib F, Khattak IH, Iqbal M. Prevalence of diabetes mellitus in Mirpur and Kotli districts of Azad Jammu & Kashmir (AJ&K). Sarhad J Agric 2007;23(4):1141-3.
21. Shera AS, Jawad F, Maqsood A. Prevalence of diabetes in Pakistan. Diabetes Research and Clinical Practice. 2007;76:219-22. (Pubitemid 46420378)
22. Silverman BL, Metzger BE, Cho NH, Loeb CA. Impaired glucose tolerance in adolescent offspring of diabetic mothers. Relationship to fetal hyperinsulinism. Diabetic Care 1995;18:611-7.
23. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetic Research and Clinical Practice. 2010;87:4-14.
24. Zhang X, Saaddine JB, Chou CF, et al. Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA 2010;304(6):649-56.
25. Yang W, Lu J, Weng J, et al. Prevalence of Diabetes among Men and Women in China. The New England Journal of Medicine. 2010;362:1090-101.
26. Seeman T, Merkin SS, Crimmins E, Koretz B, Karalamangla A. Education, income and ethnic differences in cumulative biological risk profiles in a national sample of US adults. NHANES III (1988-1994). Soc Sci Med 2008;66:72-87. (Pubitemid 350151573)
27. Steinman L. A rush to judgment on Th17. J Exp Med 2008;205(7):1517-22. (Pubitemid 351962013)
28. Tato C, Laurence A, O'Shea JJ. Helper T cell differentiation enters a new era: Le Roi est mort; vive le Roi! J Exp Med 2006;203(4):809-12.
29. Re Sandra L, Dumoutier L, Couillin I, et al. IL-17A Producing γδ T and Th17 Lymphocytes Mediate Lung Inflammation but not Fibrosis in Experimental Silicosis. J Immunol 2010;184:6367-77.
30. Lv L, Pan K, Li XD, et al. The Accumulation and Prognosis Value of Tumor Infiltrating IL-17 Producing Cells in Esophageal Squamous Cell Carcinoma. PLoS One 2011;6:(3):e18219.
31. Guangfu D, Rengao YE, Wei SHI, et al. IL-17 induces autoantibody overproduction and peripheral blood mononuclear cell overexpression of IL-6 in lupus nephritis patients. Chineas Medical Journal 2003;116(4):543-8.
32. Zeng C, Xiaoyun S, Baojun Z, et al. The imbalance of Th17/Th1/Tregs in patients with type 2 diabetes: relationship with metabolic factors and complications. J Mol Med 2012;90:175-86.
33. Honkanen J, Nieminen JK, Gao R, et al. IL-17 Immunity in Human Type 1 Diabetes. The Journal of Immunology 2010;185:1959-67.
34. Chi W, Zhu S, Yang P, Chen L. CD4+ T cells from Behcet patients produce high levels of IL-17. Eye 2011;26:65-9.
35. Nogueira E, Hamour S, Sawant D, et al. Serum IL-17 and IL-23 levels and autoantigen-specific Th17 cells are elevated in patients with ANCA-associated vasculitis. Nephrol Dial Transplant 2010;25:2209-17.
36. Zhao XF, Pan HF, Yuan H, et al. Increased serum interleukin 17 in patients with systemic lupus erythematosus. Mol Biol Rep 2009;37(1):81-5. doi: 10.1007/s11033-009-9533-3.
37. Pene J, Chevalier S, Preisser L, et al. Chronically inflamed human tissues arc infiltrated by highly differentiated Th17 lymphocytes. J Immunol 2008;180(11):7423-30.
38. Grajewski RS, Hansen AM, Agarwal RK, et al. Activation of INKT Cells Ameliorates Experimental Ocular Autoimmunity By A Mechanism Involving Innate INF-γ Production and Dampening of the Adaptive Th1 and Th17 Responses. J Immunol 2008;181(7):4791-7.